Three Faces Of Addiction Require Integrated Research Effort

Chemical addictions result from a complex interaction among biological, psychological, and social variables. Recovery requires a broad spectrum of treatments applied to each of these levels. This complexity creates a unique challenge for researchers because no single branch of science is capable of describing all aspects of addiction. While the biological sciences are necessary to describe the complex neurological and neurochemical symptoms, the psychological sciences are needed to describe the

Written byTerence Gorski
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Chemical addictions result from a complex interaction among biological, psychological, and social variables. Recovery requires a broad spectrum of treatments applied to each of these levels. This complexity creates a unique challenge for researchers because no single branch of science is capable of describing all aspects of addiction. While the biological sciences are necessary to describe the complex neurological and neurochemical symptoms, the psychological sciences are needed to describe the patterns of cognition, affective responses, and behaviors that shape and maintain the addictive process. At the same time, the social sciences are necessary to understand the social dysfunction caused by the progressive biological and psychological symptoms.

The picture is complicated by the fact that people get addicted to many different kinds of drugs, ranging from stimulants to depressants, from pain killers to hallucinogens. Each type of drug creates different biological damage and different psychological effects. Yet there seems to be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies